Search - tctmd.com

Displaying 961 - 980 of 3006

Sort: Relevancy | Date

Presentation TCT 2019

Using Dedicated Bifurcation Stents in Clinical Practice

Presenter: Carlo Briguori

September 26, 2019

Presentation TCT 2019

IVUS/OCT Guidance of Non-LM Bifurcation Stenting: When and How to Use it in Practice

Presenter: Yoshinobu Onuma

September 26, 2019

News TCT 2019

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

Shelley Wood

September 26, 2019

News Conference News TCT 2019

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups

Todd Neale

September 26, 2019

Presentation TCT 2019

MODEL U-SES: A Single-Arm Study of 3-Month DAPT in Patients Treated With a Bioabsorbable Polymer-Based Sirolimus-Eluting Stent

Presenter: Ken Kozuma

September 26, 2019

Presentation TCT 2019

EVOLVE Short DAPT: A Single-Arm Study of 3-Month DAPT in Patients at High Bleeding Risk Treated With a Bioabsorbable Polymer-Based Everolimus-Eluting Stent

Presenter: Ajay Kirtane

September 26, 2019

News Conference News TCT 2019

Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients

L.A. McKeown

September 26, 2019

https://www.tctmd.com/news/ideal-lm-probes-short-dapt-and-bioabsorbable-polymer-stent-left-main-disease

News Conference News TCT 2019

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Michael O'Riordan

September 26, 2019

Presentation TCT 2019

Onyx ONE: A Randomized Trial of a Durable-Polymer Drug-Eluting Stent vs. a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated With 1-Month DAPT

Presenter: Stephan Windecker

September 26, 2019

News Conference News TCT 2019

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Yael L. Maxwell

September 26, 2019

Presentation TCT 2019

Short and Ultrashort DAPT Strategies After Stent Implantation: What Do We Know and Where Are We Going?

Presenter: Robert Byrne

September 26, 2019

Presentation TCT 2019

The Low-Bleeding Risk Patient: Should DAPT be Tailored Based on Clinical Presentation, Anatomic Complexity or DES Type?

Presenter: Ajay Kirtane

September 26, 2019

Presentation TCT 2019

The High-Bleeding Risk Patient: Current Recommendations and Overview of Dedicated Trials

Presenter: Stephan Windecker

September 26, 2019

Presentation TCT 2019

Primer on Metallic Stents Developed in India

Presenter: Upendra Kaul

September 26, 2019

Presentation TCT 2019

Restoring Damaged Arteries With Regenerative Stents (STENTiT)

Presenter: Mari Sol Cabrera

September 26, 2019

Presentation TCT 2019

Primer on Metallic Stents Developed in China

Presenter: Run-Lin Gao

September 26, 2019

Presentation TCT 2019

Pro-Healing Stents (With Active and Passive Coatings): Latest Clinical Evidence

Presenter: Robert de Winter

September 26, 2019

Presentation TCT 2019

Polymer-Free DES: Lessons Learned From Recent Trials

Presenter: Michael Maeng

September 26, 2019

Presentation TCT 2019

Biodegradable Polymer DES: Do Clinical Trial Data Support Claims of Superior Safety or Effectiveness?

Presenter: Takeshi Kimura

September 26, 2019

Presentation TCT 2019

The Case for Further Reducing Strut Thickness: Technical Challenges and Clinical Benefits

Presenter: Sripal Bangalore

September 26, 2019

Advertisement

Using Dedicated Bifurcation Stents in Clinical Practice

IVUS/OCT Guidance of Non-LM Bifurcation Stenting: When and How to Use it in Practice

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups

MODEL U-SES: A Single-Arm Study of 3-Month DAPT in Patients Treated With a Bioabsorbable Polymer-Based Sirolimus-Eluting Stent

EVOLVE Short DAPT: A Single-Arm Study of 3-Month DAPT in Patients at High Bleeding Risk Treated With a Bioabsorbable Polymer-Based Everolimus-Eluting Stent

Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Onyx ONE: A Randomized Trial of a Durable-Polymer Drug-Eluting Stent vs. a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated With 1-Month DAPT

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Short and Ultrashort DAPT Strategies After Stent Implantation: What Do We Know and Where Are We Going?

The Low-Bleeding Risk Patient: Should DAPT be Tailored Based on Clinical Presentation, Anatomic Complexity or DES Type?

The High-Bleeding Risk Patient: Current Recommendations and Overview of Dedicated Trials

Primer on Metallic Stents Developed in India

Restoring Damaged Arteries With Regenerative Stents (STENTiT)

Primer on Metallic Stents Developed in China

Pro-Healing Stents (With Active and Passive Coatings): Latest Clinical Evidence

Polymer-Free DES: Lessons Learned From Recent Trials

Biodegradable Polymer DES: Do Clinical Trial Data Support Claims of Superior Safety or Effectiveness?

The Case for Further Reducing Strut Thickness: Technical Challenges and Clinical Benefits

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content